View in EDS

Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.

Saved in:
Bibliographic Details
Title: Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.
Authors: Yazawa S; Department of Virology, Toyama Institute of Health, Toyama, Japan., Fukuyama K; Department of Virology, Toyama Institute of Health, Toyama, Japan., Kawakami R; Department of Virology, Toyama Institute of Health, Toyama, Japan., Itamochi M; Department of Virology, Toyama Institute of Health, Toyama, Japan., Higashi D; Toyama Prefectural Central Hospital, Toyama, Japan., Tsuji N; Toyama Prefectural Central Hospital, Toyama, Japan., Nakamura M; Toyama Prefectural Central Hospital, Toyama, Japan., Oishi K; Toyama Institute of Health, Toyama, Japan., Kaya H; Toyama Prefectural Central Hospital, Toyama, Japan., Tani H; Department of Virology, Toyama Institute of Health, Toyama, Japan. Electronic address: toyamaeiken3@juno.ocn.ne.jp.
Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2025 Feb; Vol. 31 (2), pp. 102509. Date of Electronic Publication: 2024 Aug 30.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39216594
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yazawa+S%22">Yazawa S</searchLink>; Department of Virology, Toyama Institute of Health, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuyama+K%22">Fukuyama K</searchLink>; Department of Virology, Toyama Institute of Health, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+R%22">Kawakami R</searchLink>; Department of Virology, Toyama Institute of Health, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Itamochi+M%22">Itamochi M</searchLink>; Department of Virology, Toyama Institute of Health, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Higashi+D%22">Higashi D</searchLink>; Toyama Prefectural Central Hospital, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+N%22">Tsuji N</searchLink>; Toyama Prefectural Central Hospital, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+M%22">Nakamura M</searchLink>; Toyama Prefectural Central Hospital, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Oishi+K%22">Oishi K</searchLink>; Toyama Institute of Health, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Kaya+H%22">Kaya H</searchLink>; Toyama Prefectural Central Hospital, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Tani+H%22">Tani H</searchLink>; Department of Virology, Toyama Institute of Health, Toyama, Japan. Electronic address: toyamaeiken3@juno.ocn.ne.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229608375%22">Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</searchLink> [J Infect Chemother] 2025 Feb; Vol. 31 (2), pp. 102509. <i>Date of Electronic Publication: </i>2024 Aug 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9608375 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7780 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221341321X%22">1341321X </searchLink><i>NLM ISO Abbreviation: </i>J Infect Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39216594
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jiac.2024.08.024
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102509
    Titles:
      – TitleFull: Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yazawa S
      – PersonEntity:
          Name:
            NameFull: Fukuyama K
      – PersonEntity:
          Name:
            NameFull: Kawakami R
      – PersonEntity:
          Name:
            NameFull: Itamochi M
      – PersonEntity:
          Name:
            NameFull: Higashi D
      – PersonEntity:
          Name:
            NameFull: Tsuji N
      – PersonEntity:
          Name:
            NameFull: Nakamura M
      – PersonEntity:
          Name:
            NameFull: Oishi K
      – PersonEntity:
          Name:
            NameFull: Kaya H
      – PersonEntity:
          Name:
            NameFull: Tani H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1437-7780
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
              Type: main
ResultId 1